February 18, 2010 — RRD International has appointed Eric Rowinsky, M.D. to oversee oncology product development, serving as a member of the company's Product Advisory Board. Dr. Rowinsky serves as chief medical officer and executive vice president of ImClone Systems Inc. Beforehand, he served as director of clinical research at the Institute for Drug Development, as principal investigator in the AI-850 Clinical Trial at the Institute for Drug Development, and as associate professor of Oncology at Johns Hopkins University. RRD International is a biotech and pharmaceutical product development company based in Rockville.